Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients
This trial is active, not recruiting.
|Treatment||cognitive behaviour therapy|
|Sponsor||NHS Greater Clyde and Glasgow|
|Collaborator||Cancer Research UK|
|Start date||January 2003|
|End date||December 2005|
|Trial identifier||NCT00134108, C8265/A3036|
The purpose of this study is to conduct a formal controlled evaluation of the potential benefits of CBT for insomnia in cancer patients.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
Male or female participants at least 18 years old.
Inclusion Criteria: - Meets clinical criteria for insomnia. - Diagnosis of breast, prostate, colorectal or gynaecological cancer. - In follow-up phase with no further anti-cancer therapy planned. Exclusion Criteria: - Anti-cancer chemotherapy or radiotherapy within 4 weeks of trial entry. - Evidence of sleep apnoea or other sleep disorder. - Evidence of untreated major depressive disorder.
|Official title||Randomised Controlled Clinical Effectiveness Trial of Cognitive Behaviour Therapy (CBT) Versus Treatment as Usual (TAU) for Insomnia in Cancer Patients|
|Principal investigator||Colin Espie, PhD|
Call for more information